ClinicalTrials.Veeva

Menu
I

IMAX Clinical Trials, LLC. | La Palma, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Albuterol Sulfate
Fluticasone Propionate
Cadisegliatin
Verducatib
Lunsekimig
Rocatinlimab
SAR440340
Obeldesivir
Methotrexate
PF-07275315

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 14 total trials

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

This is a multicenter, randomized, double-blind, placebo-controlled phase II study assessing the efficacy, safety, and dosing regimen selection of mu...

Enrolling
Gout
Drug: Methotrexate (MTX)
Other: Placebo-Methotrexate

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. CO...

Enrolling
Moderate to Severe Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: PF-07275315-dose 2

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic m...

Active, not recruiting
Asthma
Drug: TEV-56248
Drug: Albuterol sulfate

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimi...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Lunsekimig
Drug: Placebo

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

This study is open to adults aged 40 years and older who have chronic obstructive pulmonary disease (COPD) with ongoing symptoms. People can join the...

Begins enrollment in 3 months
Chronic Obstructive Pulmonary Disease
Drug: Placebo matching verducatib
Drug: Verducatib

Trial sponsors

Sanofi logo
T
AbbVie logo
Amgen logo
Boehringer Ingelheim logo
C
Gilead Sciences logo
Pfizer logo
P
vTv Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems